Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.

The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, technological advancements, widespread smartphone usage, ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The treatment-resistant depression market size has grown significantly over recent years. From $1.76 billion in 2024, it is ...

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral ...

Spero Therapeutics (SPRO) stock jumps as GSK (GSK) partnered oral UTI treatment, tebipenem HBr, succeeds in a pivotal Phase 3 ...

Interest rates are heading downwards - to the glee of borrowers, but to the chagrin of the millions who need an income from their savings.

GlaxoSmithKline Pharmaceuticals, the Indian arm of UK-based GSK, reported a 35% year-on-year jump in consolidated net profit for the fourth quarter of FY25, driven by robust growth in its ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the ...

Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not ...

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow ...

An overwhelming 93 percent of Gen Z and young millennials said it was "appropriate" to contact colleagues who are on vacation for urgent business matters. This trend extends to their own habits as ...